Related Experiment Video
Updated: Feb 1, 2026
08:37
Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity
Published on: October 25, 2016
7.4K
Methamphetamine neurotoxicity, microglia, and neuroinflammation.
Fatemeh Shaerzadeh1, Wolfgang J Streit2, Soomaayeh Heysieattalab3
1Department of Neuroscience, University of Florida College of Medicine and McKnight Brain Institute, JHM Health Science Center, PO Box 100244, Gainesville, FL, 32610, USA.
Journal of Neuroinflammation
|December 14, 2018
Summary
Methamphetamine (METH) neurotoxicity may be less severe than previously thought. Microglial activation in animal models is modest, suggesting limited dopaminergic neuron damage and questioning anti-inflammatory treatment benefits for METH addiction.
Area of Science:
- Neuroscience
- Immunology
- Toxicology
Background:
- Methamphetamine (METH) abuse is a global issue.
- METH's effects on dopamine neurotransmission and neurotoxicity are known.
- Recent focus on METH's impact on microglial neuroimmune function and neuroinflammation.
Purpose of the Study:
- To review METH-induced neurotoxicity from a neuropathological viewpoint.
- To summarize studies on microglial activation following METH administration in rodents.
- To assess microglial reactivity for understanding METH's neuronal effects.
Main Methods:
- Review of published studies on METH administration in rodent models.
- Analysis of microglial activation based on morphology and immunophenotype.
- Assessment of neuroinflammation and dopaminergic neurotoxicity.
Main Results:
- Microglial activation intensity after METH administration in most animal models is modest.
- The extent of direct dopaminergic neuron damage caused by METH appears relatively minor.
- Findings contrast with claims of excessive neuroinflammation exacerbating METH neurotoxicity.
Conclusions:
- The study's analysis does not support the notion of significant METH-induced neuroinflammation.
- Direct dopaminergic neuron damage from METH may be less extensive than often claimed.
- Suppression of microglial activity with anti-inflammatory agents may not be beneficial for treating METH addiction disorders.
